Results 1 to 10 of about 31 (31)

Examination of the Effectiveness of Direct Oral Anticoagulants in Comparison to Warfarin in an Obese Population. [PDF]

J Pharm Technol, 2022
Watson RM, Smith CB, Crannage EF, Challen LM.   +3 more
europepmc   +1 more source

PAX9 in Cancer Development. [PDF]

Int J Mol Sci, 2022
Chen X, Li Y, Paiboonrungruang C, Li Y, Peters H, Kist R, Xiong Z.   +6 more
europepmc   +1 more source

A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target. [PDF]

Lab Invest, 2022
Franceschini N, Gaeta R, Krimpenfort P, Briaire-de Bruijn I, Kruisselbrink AB, Szuhai K, Palubeckaitė I, Cleton-Jansen AM, Bovée JVMG.   +8 more
europepmc   +1 more source

Epigenetic reprogramming of Runx3 reinforces CD8 + T-cell function and improves the clinical response to immunotherapy. [PDF]

Mol Cancer, 2023
Liu Z, Li X, Gao Y, Liu J, Feng Y, Liu Y, Wang J, Wang C, Wang D, He J, Han W, Mei Q, Sun Y.   +12 more
europepmc   +1 more source

A multicentric quality-control study of exercise Doppler echocardiography of the right heart and the pulmonary circulation. The RIGHT Heart International NETwork (RIGHT-NET). [PDF]

Cardiovasc Ultrasound, 2021
Ferrara F, Ferrara F, Ferrara F, Gargani L, Contaldi C, Agoston G, Argiento P, Armstrong WF, Bandera F, Cademartiri F, Citro R, Cittadini A, Cocchia R, D'Alto M, D'Andrea A, Douschan P, Ghio S, Grünig E, Guazzi M, Guida S, Kasprzak JD, Kolias TJ, Limongelli G, Marra AM, Mazzola M, Mauro C, Moreo A, Pieri F, Pratali L, Pugliese NR, Raciti M, Ranieri B, Rudski L, Saggar R, Salzano A, Serra W, Stanziola AA, Vannan M, Voilliot D, Vriz O, Wierzbowska-Drabik K, Naeije R, Bossone E, RIGHT Heart International NETwork (RIGHT-NET) Investigators.   +43 more
europepmc   +1 more source

Application of two-dimensional difference gel electrophoresis to identify protein changes between center, margin, and adjacent non-tumor tissues obtained from non-small-cell lung cancer with adenocarcinoma or squamous cell carcinoma subtype. [PDF]

PLoS One, 2022
Ciereszko A, Dietrich MA, Słowińska M, Nynca J, Ciborowski M, Kaczmarek MM, Myszczyński K, Kiśluk J, Majewska A, Michalska-Falkowska A, Kodzik N, Reszeć J, Sierko E, Nikliński J.   +13 more
europepmc   +1 more source

Molecular profiling of microinvasive breast cancer microenvironment progression. [PDF]

J Transl Med, 2019
Lessi F, Scatena C, Aretini P, Menicagli M, Franceschi S, Naccarato AG, Mazzanti CM.   +6 more
europepmc   +1 more source

BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma. [PDF]

Cancer, 2013
Pennington KP, Walsh T, Lee M, Pennil C, Novetsky AP, Agnew KJ, Thornton A, Garcia R, Mutch D, King MC, Goodfellow P, Swisher EM.   +11 more
europepmc   +1 more source

Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma. [PDF]

Front Genet, 2018
An P, Xu J, Yu Y, Winkler CA.
europepmc   +1 more source

Micronuclei in cord blood lymphocytes and associations with biomarkers of exposure to carcinogens and hormonally active factors, gene polymorphisms, and gene expression: the NewGeneris cohort. [PDF]

Environ Health Perspect, 2014
Merlo DF, Agramunt S, Anna L, Besselink H, Botsivali M, Brady NJ, Ceppi M, Chatzi L, Chen B, Decordier I, Farmer PB, Fleming S, Fontana V, Försti A, Fthenou E, Gallo F, Georgiadis P, Gmuender H, Godschalk RW, Granum B, Hardie LJ, Hemminki K, Hochstenbach K, Knudsen LE, Kogevinas M, Kovács K, Kyrtopoulos SA, Løvik M, Nielsen JK, Nygaard UC, Pedersen M, Rydberg P, Schoket B, Segerbäck D, Singh R, Sunyer J, Törnqvist M, van Loveren H, van Schooten FJ, Vande Loock K, von Stedingk H, Wright J, Kleinjans JC, Kirsch-Volders M, van Delft JH, NewGeneris Consortium.   +45 more
europepmc   +1 more source